In certain patients, JAK inhibitor rescue medications seem to be more effective, researche ...

EEN is primarily used for Crohn's disease, but its effectiveness in ulcerative colitis is unclear, necessitating further research. A systematic review analyzed 70 studies, finding no significant ...

Palisade Bio, Inc. announced positive preclinical results for its drug candidate PALI-2108 at the 2025 Crohn’s and Colitis Congress, showing its efficacy in reducing colitis symptoms in a DSS mouse ...

Ulcerative colitis is a chronic condition characterized by inflammation and ulcers in the colon. Research is ongoing to expand treatment options. A study published in the New England Journal of ...

Focal active colitis (FAC) is when a specific type of white blood cell enters tiny structures in the colon wall, causing inflammation. Various conditions can lead to FAC, such as Crohn’s disease.

Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

Lymphocytic colitis is a type of microscopic colitis that causes persistent, watery diarrhea. Experts still do not know the exact underlying cause. Microscopic colitis involves inflammation of the ...